x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > 7th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
Print

Description

ESO Chair: A. Eniu, CH 
ESMO Chair: R. Obermannová, CZ
Host Chair:
E. Vrdoljak, HR
Masterclass Coordinator: N. Pavlidis, GR
Advisers: T. Cufer, SI - G. Prager, AT

INTRODUCTION
This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology.
The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided.

LEARNING OBJECTIVES
• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology

THE MASTERCLASS IS:
• A five day residential, educational event
• Full immersion
• Clinically oriented
• Multidisciplinary

MAIN TOPIC
• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Symptom management in gynaecological cancers
• Head and neck cancers
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies

The Eastern Europe
and Balkan Region Masterclass in
Medical Oncology is an
ESO-ESMO joint event

     

 
In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document

Faculty

INVITED FACULTY
Joerg Beyer, Inselspital Bern, Oncology and Medicine Dpt., Bern, CH
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia: ESMO Designated Centre of Integrated Oncology and Palliative Care, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Etienne Brain, Institut Curie, Medical Oncology Dpt., Saint-Cloud, FR
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Stefano Cascinu, Università Vita-Salute San Raffaele, Dept. of Oncology/Hematology, Milano, IT
Tanja Cufer, University Clinic Golnik, Medical Oncology Unit, Golnik, SI
Alexandru Eniu, Riviera-Chablais Vaud-Valais, Interdisciplinary Oncology Service (SIC), Rennaz, CH
Fady B. Geara, American University of Beirut Medical Center, Dept. of Radiation Oncology, Riad El Solh, Beirut, LB
Dragana Jovanovic, Internal Medicine Clinic "Akta Medica", Dept. of Thoracic Oncology, Belgrade, RS
Izidor Kern, University Clinic Golnik, Dept. of Pathology, Golnik, SI
Salvador E. Martin Algarra, Clinica Universidad de Navarra, Medical Oncology Dept., Pamplona, Navarra, ES
Radka Obermannova, Masaryk Memorial Cancer Institute, Department Of Clinical Oncology, Brno, CZ
Tomislav Omrcen, University Hospital of Split, Medical School of Split, Oncology Dept., Split, HR
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Nicholas Pavlidis, University Hospital of Ioannina, Medical Oncology Dpt., Ioannina, GR
Razvan Popescu, Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Marta Porebiak, SWPS University of Social Sciences and Humanities, Faculty of Psychology, Warsaw, PL
Gerald Prager, MUW, Department of Medicine 1, Vienna, AT
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Christos Sotiriou, Institut Jules Bordet, Breast Cancer Translational Research Laboratory J.C. Heuson-, Brussels, BE
Snjezana Tomic, Clinical Institute of Pathology KBC Split, Faculty of Medicine, Split, HR
Jan Baptist Vermorken, Antwerp University Hospital, Medical Oncology Dpt., Edegem, BE
Eduard Vrdoljak, Clinical Hospital Split, Medical School Split, Clinic Of Oncology And Radiotherapy, Split, HR
Christoph Zielinski, Central European Cooperative Oncology Group, Clinical Division of Oncology, Vienna, AT
Emanuele Zucca, Oncology Institute of Southern Switzerland (IOSI), Dept. of Medical Oncology, Bellinzona, CH

General information

ORGANISING SECRETARIAT
Dolores Knupfer
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
CH 6500 Bellinzona - Switzerland
Tel: +41 91 820 0952
Fax: +41 91 820 0953
Email: dknupfer@eso.net

LANGUAGE
The Masterclass will be held in English and translation will not be provided.

INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

ACCREDITATION
Application for CME recognition will be submitted to the European Society for Medical Oncology (ESMO) for ESMO-MORA accreditation, to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.

ESCO CREDITS




Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.

A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

Application

PARTICIPANT’S PROFILE OF THE MASTERCLASS CANDIDATE

  • Age between 30 and 40 years
  • 2-3 years’ experience in medical oncology
  • Involvement in scientific activities and clinical trials
  • Fluency in English

HOW TO APPLY

Interested oncologists should apply online (at the top of this page) providing:

  • Letter describing motivation for attending;
  • Supporting letter from head of department or mentor;
  • CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
  • Clinical case (see below)

Priority will be given to candidates practicing in Eastern Europe and Balkan region countries.

CLINICAL CASE PRESENTATION

Submit an abstract of one page on the template (form available at the bottom of this page), describing a clinical case related to one of the subjects of the Masterclass (lung, genitourinary, breast, head-and-neck, gastrointestinal and gynaecological cancers). You will have to present your case at the Masterclass in format of a clinical grand round discussion. Please provide straightforward a case of your daily clinical practice - no uncommon or extremely rare cases. A maximum of 10 slides will be permitted containing:

  • Diagnostic considerations
  • Treatment
  • Results, follow-up
  • At least three questions proposed for discussion with the faculty

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event dedicated website will be created and all questionnaires and certificates will be accessible only from there. Any potential problems with meeting this request should be communicated to the secretariat as part of the application process.

 

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY

Successful applicants are granted free registration and full board accommodation.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.

APPLICATION DEADLINE: 1 June 2021

 

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

TEMPLATES

  • Download HERE your Professional experience template
  • Download HERE your Abstract template

Programme

15 October

16:30Registration
17:00Welcome address and general introduction
Alexandru Eniu, CH - Radka Obermannova, CZ - Nicholas Pavlidis, GR - Eduard Vrdoljak, HR
17:15Access to care: an old/new issue? Global and eastern European issues
Alexandru Eniu, CH
17:35Access to diagnoses and drugs in NSCLC in central and southeastern Europe
Tanja Cufer, SI
17:50Spotlight session 1: IPOS lecture - Communication skills as first level psycho-social care
Marta Porebiak, PL
20:00Dinner

16 October

 GYNAECOLOGICAL CANCER SESSION
Cristiana Sessa, CH - Jan Baptist Vermorken, BE
 8:30Systemic management of ovarian cancer
Jan Baptist Vermorken, BE
 9:10Systemic management of metastatic/advanced cervical and endometrial cancer
Cristiana Sessa, CH
 9:50Coffee break
 10:20Tumour board on gynaecological cancers
 GENITO-URINARY TUMOURS SESSION
Joerg Beyer, CH - Fady B. Geara, LB
 11:10Local therapy for prostate cancer (surgery and radiotherapy)
Fady B. Geara, LB
 11:40First line endocrine therapy in endocrine sensitive prostate cancer
Joerg Beyer, CH
 12:15Lunch
 13:50Treatment of endocrine resistant and refractory prostate cancer
Joerg Beyer, CH
 14:30Update in the management of renal cancer
Joerg Beyer, CH
 15:10Systemic treatment of advanced and metastatic bladder cancer
Tomislav Omrcen, HR
 15:50Tumour board on genito-urinary tumours
19:30Dinner

17 October

 BREAST CANCER SESSION
Tanja Cufer, SI - Eduard Vrdoljak, HR
 8:30Breast cancer pathology and molecular biology
Snjezana Tomic, HR
 9:00Optimal surgical management of breast cancer
Maria-João Cardoso, PT
 9:40The role of radiotherapy in early and advanced breast cancer
Eduard Vrdoljak, HR
 10:20Coffee break
 10:50Optimal approach in locally advanced disease: ESO-ESMO-ABC Guidelines
Alexandru Eniu, CH
 11:30Systemic treatment of luminal early and advanced breast cancer
Alexandru Eniu, CH
 12:10Systemic treatment of HER2-positive early and advanced BC
Tanja Cufer, SI
 12:50Lunch
 13:50Systemic treatment of TN early and advanced BC
Christos Sotiriou, BE
 14:30Cancer genomics for the practising oncologist
Christos Sotiriou, BE
 15:00Tumor board on breast cancer
 PARALLEL BREAST CANCER GROUPS
 15:45Group A
Alexandru Eniu, CH
 15:45Group B
Tanja Cufer, SI
 15:45Group C
Christos Sotiriou, BE
19:30Dinner

18 October

8:30Spotlight session 2: Management of non-Hodgkin's lymphomas
Emanuele Zucca, CH
9:40Spotlight session 3: Management of advanced head and neck
Jan Baptist Vermorken, BE
 LUNG CANCER AND MESOTHELIOMA SESSION
Tanja Cufer, SI - Dragana Jovanovic, RS
 10:50Lung cancer pathology and molecular biology
Izidor Kern, SI
 11:20The impact of radiation therapy in lung cancer
Fady B. Geara, LB
 11:50Systemic therapy for NSCLC without oncogenic driver mutations: focus on immune therapy
 12:30Systemic therapy for NSCLC with oncogenic driver mutations
Tanja Cufer, SI
 14:10Standard of care of SCLC and future directions
Dragana Jovanovic, RS
 14:50Tumor board on lung cancer
15:35PARALLEL LUNG CANCER GROUPS
 15:35Group A
Tanja Cufer, SI
 15:35Group B
Dragana Jovanovic, RS
19:30Dinner

19 October

8:15Spotlight session 4: Benefits of early integration of cancer care and palliative care in oncology
Snezana Bosnjak, RS
8:35Spotlight session 5: Supportive care
Snezana Bosnjak, RS
8:55Spotlight session 6: Management of cancer in the elderly
Etienne Brain, FR
9:15Tumor board on palliative and supportive care
Etienne Brain, FR - Razvan Popescu, CH
10:00Coffee break
 GASTRO-INTESTINAL TUMOURS SESSION
Stefano Cascinu, IT - Demetris Papamichael, CY
 11:10Systemic treatment of advanced colorectal cancer
Demetris Papamichael, CY
 11:50Adjuvant/neo-adjuvant therapy in GEJ/Stomach adenocarcinoma
Stefano Cascinu, IT
 12:30Optimal management of metastatic gastric cancer in 2020
Stefano Cascinu, IT
 13:10Lunch
 14:10Management of rectal cancer
Gerald Prager, AT
 14:40Management of advanced pancreatic cancer
Razvan Popescu, CH
 15:15Tumour board on gastro-intestinal tumours
16:00PARALLEL GASTRO-INTESTINAL TUMOUR GROUPS
 16:00Group A
Demetris Papamichael, CY
 16:00Group B
Stefano Cascinu, IT
 16:00Group C
Razvan Popescu, CH
19:30Dinner

20 October

8:30Spotlight session 7: Immune check point inhibitors: Immunologic background, indications and innovations
Christoph Zielinski, AT
9:15Spotlight session 8: Management of melanoma with immunotherapy and targeted treatment
Salvador E. Martin Algarra, ES
10:00LEARNING SELF-ASSESSMENT TEST
11:00The diagnostic and therapeutic management of Cancer of Unknown Primary
Nicholas Pavlidis, GR
11:30Announcement of LATS Results and Awards
11:45Closing remarks and departures